CB Scientific Inc
Cardiac Biotech Solutions Inc., through its subsidiaries, provides ambulatory non-invasive cardiac monitoring products and services in the United States and internationally. It offers My-Cardia devices, interactive cloud-based acquisition software, and smartphone apps for patients at risk of abnormal heart rhythms. The company was formerly known as CB Scientific, Inc. and changed its name to Card… Read more
CB Scientific Inc (CBSC) - Total Assets
Latest total assets as of December 2025: $377.33K USD
Based on the latest financial reports, CB Scientific Inc (CBSC) holds total assets worth $377.33K USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
CB Scientific Inc - Total Assets Trend (2016–2025)
This chart illustrates how CB Scientific Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
CB Scientific Inc - Asset Composition Analysis
Current Asset Composition (March 2025)
CB Scientific Inc's total assets of $377.33K consist of 55.2% current assets and 44.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 29.9% |
| Accounts Receivable | $6.50K | 3.9% |
| Inventory | $27.89K | 16.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how CB Scientific Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CB Scientific Inc's current assets represent 55.2% of total assets in 2025, an increase from 53.5% in 2016.
- Cash Position: Cash and equivalents constituted 29.9% of total assets in 2025, up from -0.7% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 16.7% of total assets.
CB Scientific Inc Competitors by Total Assets
Key competitors of CB Scientific Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
CB Scientific Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - CB Scientific Inc generates 0.25x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - CB Scientific Inc is currently not profitable relative to its asset base.
CB Scientific Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.19 | 0.09 | 0.02 |
| Quick Ratio | 0.17 | 0.07 | 0.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.63 Million | $ -1.57 Million | $ -1.24K |
CB Scientific Inc - Advanced Valuation Insights
This section examines the relationship between CB Scientific Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 261.27 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -44.3% |
| Total Assets | $167.44K |
| Market Capitalization | $341.53 USD |
Valuation Analysis
Below Book Valuation: The market values CB Scientific Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: CB Scientific Inc's assets decreased by 44.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for CB Scientific Inc (2016–2025)
The table below shows the annual total assets of CB Scientific Inc from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $167.44K | -44.26% |
| 2024-03-31 | $300.36K | -1.47% |
| 2023-03-31 | $304.85K | -53.39% |
| 2022-03-31 | $653.97K | +109.72% |
| 2021-03-31 | $311.84K | +187.17% |
| 2020-03-31 | $108.59K | +201.81% |
| 2019-03-31 | $35.98K | -40.58% |
| 2018-03-31 | $60.56K | -10.48% |
| 2017-03-31 | $67.65K | -45.07% |
| 2016-03-31 | $123.16K | -- |